HUNTSVILLE, AL / ACCESSWIRE / August 14, 2024 / Kalm Therapeutics is pleased to announce the $700,000 oversubscribed closing of its seed round to bring the first prescription patch treatment to eczema ...
Huntsville, Alabama--(Newsfile Corp. - September 16, 2024) - Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief Medical Officer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results